Applicant, as named in the Orange Book

Takeda Pharms Am

Next listed expiry: Mimrylo on 17 Mar 2034. 1 products with live protection, 0 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Mimrylo · 5 strengths rusfertide acetate	rusfertide acetate	220605	17 Mar 2034	patent

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.